26-18-105.   Drug prior approval program.
Any drug prior approval program approved or implemented by the board shall
meet the following conditions:
(1)  no drug may be placed on prior approval for other than medical reasons;
(2)  the board shall hold a public hearing at least 90 days prior to placing a
drug on prior approval;
(3)  notwithstanding the provisions of Section 52-4-202, the board shall
provide not less than 30 days notice to the public before holding a public
hearing under Subsection (2);
(4)  the board shall consider written and oral comments submitted by
interested parties prior to or during the hearing held in accordance with
Subsection (2);
(5)  the board shall provide evidence that placing a drug class on prior
approval will not impede quality of recipient care and that the drug class is
subject to clinical abuse or misuse;
(6)  no later than nine months after any drug class is placed on prior
approval, it shall be reconsidered in a public hearing with notice as provided
in Subsection (3);
(7)  the program shall provide either telephone or fax approval or denial at
least Monday through Friday, within 24 hours after receipt of the prior
approval request;
(8)  the program shall provide for the dispensing of at least a 72-hour supply
of the drug in an emergency situation or on weekends;
(9)  the program may not be applied to prevent acceptable medical use for
appropriate off-label indications; and
(10)  any drug class placed on prior approval shall receive a majority vote by
the board for that placement, after meeting the requirements described in
Subsections (1) through (10).
